Alpha Centric Advisors LLC Pacira Bio Sciences, Inc. Transaction History
Alpha Centric Advisors LLC
- $144 Million
- Q1 2024
A detailed history of Alpha Centric Advisors LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 117,500 shares of PCRX stock, worth $2.37 Million. This represents 2.38% of its overall portfolio holdings.
Number of Shares
117,500
Previous 117,500
-0.0%
Holding current value
$2.37 Million
Previous $3.96 Million
13.4%
% of portfolio
2.38%
Previous 3.09%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
290Shares Held
48.6MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$160 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$103 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$38.7 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$38.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$38 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $926M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...